IBM spent more than a decade trying to make a go of Watson Health, its moonshot to apply artificial intelligence in healthcare. Watson was supposed to revolutionize everything from diagnosing patients and recommending treatment options to finding candidates for clinical trials.
Now, after billions invested and a series of high-profile setbacks, the company is effectively selling Watson for parts to private equity firm Francisco Partners.
Where did Watson Health miss the mark?
Read the full article at Quartz.
This article was produced by Footnote in partnership with Abridge.